Brief: Phathom Pharmaceuticals Announces Commercial Availability Of Voquezna® (Vonoprazan) Tablets, A Powerful First-In-Class Pcab For The Treatment Of Erosive Gerd And Relief Of Associated Heartburn
28/11/2023 15:29
Phathom Pharmaceuticals Inc PHAT.O :
* PHATHOM PHARMACEUTICALS ANNOUNCES COMMERCIAL AVAILABILITY
OF
VOQUEZNA® (VONOPRAZAN) TABLETS, A POWERFUL FIRST-IN-CLASS PCAB
FOR THE TREATMENT OF EROSIVE GERD AND RELIEF OF ASSOCIATED
HEARTBURN
* PHATHOM PHARMACEUTICALS INC: IS NOW AVAILABLE THROUGH
MAJOR
RETAIL PHARMACIES AND BLINKRX
Source text for Eikon: ID:nGNX7y9hXz
Further company coverage: PHAT.O
Recent news on Phathom Pharmaceuticals
See all newsBrief: Phathom Pharma Provides Update On Litigation Filed By BDR Pharma Against FDA
Phathom Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Phathom Pharmaceuticals Q2 revenue beats on Voquezna prescription growth
Brief: Phathom Pharmaceuticals Q2 Net Income USD -17.582 Million
Phathom Pharmaceuticals Q1 revenue more than doubles, beats estimates